Xenon Pharmaceuticals Inc (XENE) Insider Trading
- $2,644,542.40
- $39,081,291.05
- March 13, 2026
- Simon N Pimstone
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 13, 2026 | Insider | 1,342 | $55.23 | Sell | $74,118.66 | |
| March 13, 2026 | CEO | 7,308 | $55.23 | Sell | $403,620.84 | |
| March 13, 2026 | Insider | 1,410 | $55.23 | Sell | $77,874.30 | |
| March 10, 2026 | Insider | 2,771 | $60.11 | Sell | $166,564.81 | |
| March 10, 2026 | CEO | 11,269 | $60.11 | Sell | $677,379.59 | |
| March 10, 2026 | Insider | 2,607 | $60.11 | Sell | $156,706.77 | |
| March 9, 2026 | CEO | 270,000 | $60.33 | Sell | $16,289,100.00 | |
| June 5, 2025 | Director | 3 | $30.48 | Sell | $91.44 | |
| Jan. 27, 2025 | CEO | 16,315 | $40.50 | Sell | $660,757.50 | |
| Jan. 24, 2025 | CEO | 22,468 | $40.20 | Sell | $903,213.60 | |
| Dec. 18, 2024 | CFO | 18,709 | $41.21 | Sell | $770,997.89 | |
| Nov. 22, 2024 | Director | 4,891 | $41.08 | Sell | $200,922.28 | |
| March 7, 2024 | EVP | 7,137 | $46.28 | Sell | $330,300.36 | |
| March 7, 2024 | Director | 13,000 | $46.28 | Sell | $601,640.00 | |
| Dec. 13, 2023 | Director | 11,380 | $39.29 | Sell | $447,120.20 | |
| Aug. 24, 2023 | Director | 25,000 | $38.70 | Sell | $967,500.00 | |
| May 31, 2023 | Director | 62,526 | $38.70 | Sell | $2,419,756.20 | |
| May 24, 2023 | CEO | 31,655 | $41.41 | Sell | $1,310,833.55 | |
| March 24, 2023 | Insider | 700 | $35.01 | Sell | $24,507.00 | |
| March 7, 2023 | Director | 19,232 | $36.98 | Sell | $711,199.36 | |
| Nov. 25, 2022 | Director | 1,937 | $34.79 | Sell | $67,388.23 | |
| Nov. 23, 2022 | Director | 2,057 | $34.33 | Sell | $70,616.81 | |
| Aug. 15, 2022 | Director | 33,942 | $37.76 | Sell | $1,281,649.92 | |
| Aug. 12, 2022 | EVP | 57,743 | $38.31 | Sell | $2,212,134.33 | |
| Aug. 12, 2022 | Director | 91,135 | $38.28 | Sell | $3,488,647.80 | |
| March 7, 2022 | Director | 31,086 | $30.50 | Sell | $948,123.00 | |
| March 7, 2022 | EVP | 32,853 | $30.54 | Sell | $1,003,330.62 | |
| March 4, 2022 | Director | 9,325 | $30.61 | Sell | $285,438.25 | |
| March 4, 2022 | EVP | 21,710 | $30.50 | Sell | $662,155.00 | |
| Jan. 21, 2022 | Insider | 700 | $28.81 | Buy | $20,167.00 | |
| Dec. 6, 2021 | Insider | 4,000 | $24.40 | Buy | $97,600.00 | |
| Nov. 15, 2021 | Director | 17,557 | $31.33 | Sell | $550,060.81 | |
| May 28, 2021 | EVP | 6,067 | $18.81 | Sell | $114,120.27 | |
| May 27, 2021 | Director | 11,064 | $18.68 | Sell | $206,675.52 | |
| June 1, 2020 | CEO | 3,000 | $14.43 | Sell | $43,290.00 | |
| May 29, 2020 | CEO | 5,000 | $13.99 | Sell | $69,950.00 | |
| Sept. 20, 2019 | CEO | 10,395 | $9.51 | Sell | $98,856.45 | |
| Sept. 19, 2019 | Director | 7,600 | $9.27 | Sell | $70,452.00 | |
| Sept. 17, 2019 | Director | 5,069 | $9.32 | Sell | $47,243.08 | |
| Sept. 13, 2019 | Director | 23 | $9.31 | Sell | $214.13 | |
| Nov. 15, 2017 | Director | 15,000 | $2.22 | Buy | $33,300.00 | |
| Sept. 22, 2017 | Director | 10,000 | $2.95 | Buy | $29,500.00 | |
| Aug. 18, 2017 | Director | 6,335 | $2.90 | Buy | $18,371.50 | |
| Aug. 18, 2017 | Insider | 1,000 | $3.00 | Buy | $3,000.00 | |
| Aug. 15, 2017 | SVP | 10,000 | $2.48 | Buy | $24,800.00 | |
| Aug. 15, 2017 | Major Shareholder | 18,858 | $2.41 | Buy | $45,447.78 | |
| Aug. 15, 2017 | Insider | 60,202 | $2.61 | Buy | $157,127.22 | |
| Aug. 14, 2017 | Major Shareholder | 41,344 | $2.70 | Buy | $111,628.80 | |
| Aug. 14, 2017 | Director | 15,000 | $2.75 | Buy | $41,250.00 | |
| Aug. 11, 2017 | Director | 15,000 | $2.82 | Buy | $42,300.00 |
Insiders are both buying and selling Xenon Pharmaceuticals Inc stock.
The insider traders at Xenon Pharmaceuticals Inc are: Simon N Pimstone, Ian Mortimer, Frank A Holler, Gary Patou, Value Fund L P Biotechnology, Christopher John Kenney, Mohammad Azab, Sherrington Robin, James R Empfield, Steven Gannon, Andrea Difabio, Bvf Partners L P/Il, Seggern Christopher Von, Richard H Scheller, Sherry Aulin, Raymond Winquist, Michael R Hayden, Dawn Svoronos, and Y. Paul Goldberg
The most active insider trader at Xenon Pharmaceuticals Inc is Simon N Pimstone with 11 trades.
Ian Mortimer has sold the most Xenon Pharmaceuticals Inc stock with a total value of $20,648,525.92.
Value Fund L P Biotechnology has bought the most Xenon Pharmaceuticals Inc stock with a total value of $2,205,788.54.
The most recent insider trade for Xenon Pharmaceuticals Inc was on March 13, 2026.
The single biggest insider buy for Xenon Pharmaceuticals Inc was from Value Fund L P Biotechnology with a total value of $1,366,639.38 on June 7, 2017.
The single biggest insider sell for Xenon Pharmaceuticals Inc was from Ian Mortimer with a total value of $16,289,100.00 on March 9, 2026.
